Drug Shortage Report for MYLAN-PANTOPRAZOLE

Last updated on 2018-07-05 History
Report ID 200
Drug Identification Number 02299585
Brand name MYLAN-PANTOPRAZOLE
Common or Proper name PANTOPRAZOLE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) PANTOPRAZOLE
Strength(s) 40MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL
Packaging size 500BT, 100BT
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-07-03
Actual start date 2018-07-03
Estimated end date Unknown
Actual end date 2018-07-03
Shortage status Resolved
Updated date 2018-07-05
Company comments Discontinued in ID 51513
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v41 2018-01-08 French Compare
v42 2018-01-10 English Compare
v43 2018-01-10 French Compare
v44 2018-01-12 English Compare
v45 2018-01-12 French Compare
v46 2018-01-17 English Compare
v47 2018-01-17 French Compare
v48 2018-01-19 English Compare
v49 2018-01-19 French Compare
v50 2018-01-26 English Compare
v51 2018-01-26 French Compare
v52 2018-02-02 English Compare
v53 2018-02-02 French Compare
v54 2018-02-16 English Compare
v55 2018-02-16 French Compare
v56 2018-02-23 English Compare
v57 2018-02-23 French Compare
v58 2018-02-27 English Compare
v59 2018-02-27 French Compare
v60 2018-03-05 English Compare

Showing 41 to 60 of 72